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FINAL EXAMINATION DURATION 
PHA213 – Pharmacology 2 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
The examination has 2 (A and B) Sections: 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions in the Faculty/School 
supplied Multiple Choice Answer Sheet.  Total marks allocated: Twenty (20).  Suggested time allocation: 
One (1) hour. 
Section B contains Ten (10) Extended-Answer Questions.  Answer any eight (8) questions only in the 20-
page Booklet provided.  Total marks allocated: Eighty (80).  Suggested time allocation: Two (2) hours.   





This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
Answer on the supplied examination material/s only 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 
No additional printed material is permitted 
 
1 x 20 Page Book 
Faculty/School Multiple Choice Answer Sheet 
  
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM 
ANY EXAMINATION VENUE IN ANY CIRCUMSTANCE. THIS EXAMINATION IS PRINTED DOUBLE-SIDED. 
 
Semester 2, 2015 FINAL EXAMINATION 
 PHA213 – Pharmacology 2 









THIS EXAMINATION IS PRINTED 
DOUBLE-SIDED. 
 




THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM 
ANY EXAMINATION VENUE IN ANY CIRCUMSTANCE. THIS EXAMINATION IS PRINTED DOUBLE-SIDED. 
 
Semester 2, 2015 FINAL EXAMINATION 
 PHA213 – Pharmacology 2 
Page 3 of 7 
Section A 
Multiple Choice Questions 
Total No of Marks for this section: 20 
 
The answers for this section must be written on the Faculty/School Multiple Choice Answer 
Sheet provided.  Please ensure that you write your name and student number on the Answer 
Sheet. 
Answer ALL (40) questions. 
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Sections B  
Extended Answer Questions 
Total No. of Marks for these Sections: 80 
 
These sections must be answered in the Answer Booklets provided. 
Answer ANY EIGHT (8) questions only. 
 




Describe the mechanism of action of the following agents in producing bacteriostatic or 
bactericidal effect.  Identification of susceptible microorganisms or therapeutic applications is 
not required.  For part a, explain the benefit of using this combined preparation. 
a Amoxycillin with clavulanic acid (4 marks) 
b Roxithromycin (2 marks) 
c Norfloxacin (2 marks) 






Describe the mechanism of action of the following cancer chemotherapeutic agents.  
Identification of therapeutic applications is required for part a and part c (name ONE (1) 
each). 
a Anastrazole (3 marks) 
b Bevacizumab (2 marks) 
c Colaspase (also known as L-asparaginase) (3 marks) 
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Question 3 (multiple topics) 
a Two patients being treated with a neuroleptic Serenace (haloperidol) develop 
symptoms of involuntary movements.  On reducing the dosage, patient A’s condition 
improves while patients B’s condition worsens.  Explain what has probably happened 
in each case and suggest ONE (1) agent which may be useful to resolve patient B’s 
symptoms, including its mechanism of action. 
 (6 marks) 
b Describe the action and use of sumatriptan in the management of migraine.  What are 
the precautions when using this agent? 





a Describe in detail the mechanisms of action of the following therapeutic agents in 
improving depression. 
i. Fluoxetine 
ii. Phenelzine (4 marks) 
b Strict dietary advice must be given to patients using one of these medications.  Explain 
what can happen, including the mechanism for its occurrence, if this advice is not 
followed. 





The following agents are used in the management of pain.   Describe their mechanisms in 
inhibiting pain transmission, and the circumstances (origin and intensity of pain) where each 
of these agents is preferred. 
a Morphine (4 marks) 
b Ibuprofen (3 marks) 
c Carbamazepine (3 marks) 
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Question 6 
a What advantages, if any, do the synthetic corticosteroids have over the natural hormone 
cortisol? 
 (2 marks) 
b Outline the therapeutic uses of glucocorticoids (for example beclomethasone) in non-
endocrine disease and SIX (6) adverse effects associated with long-term 
administration. 
 (5 marks) 
c How can these adverse effects (in b) be managed or avoided? 





a Explain how the physicochemical properties of inhaled general anaesthetics can 
determine their speeds of onset of action and their potencies. 
 (5 marks) 
b Name TWO (2) different classes of adjuncts which are used to enhance surgical 
anaesthesia.  Describe their mechanisms of action and explain the advantages of using 
these agents. 




Question 8 (multiple topics) 
a Discuss the THREE (3) pharmacologically-useful properties of therapeutic agents used 
for epilepsy.  Give examples. 
 (6 marks) 
b Describe the mechanisms of action of TWO (2) different classes of therapeutic agents 
commonly used to manage Parkinson’s disease. 
 (4 marks) 
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Question 9 
BB took a few temazepam tablets with some alcoholic drinks.  Shortly afterwards, he was 
found minimally responsive with slow and shallow breathing. 
a Explain what has probably happened.  Include in your answer the mechanism of 
action of temazepam. 
 (5 marks) 
b How could BB be treated? 
 (2 marks) 
c Explain the differences between temazepam and pentobarbitone (a barbiturate) with 
regard to their mechanisms of action and the clinical consequences of drug overdose. 




Question 10 (multiple topics) 
a Describe how ethanol is eliminated from the body (drawing a flow diagram without an 
explanatory note is NOT an acceptable answer).  Include in your answer the enzymes 
involved and the rate limiting factor. 
 (6 marks) 
b Describe what is in the combined oral contraceptive pills and how these agents produce 
their effects on the female reproductive cycle to prevent pregnancy. 







End of Section B 
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